KRAS and NRAS genes mutations as biomarkers in the therapy of colorectal cancer and the basic methods of their detection

Determination of the mutations' status in the KRAS and NRAS genes is a necessary requirement in the treatment of patients with colorectal cancer (CRC). Patients with certain mutations in the KRAS and NRAS genes are resistant to anti-EGFR drug therapy and have a lower median survival rate than t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Olga I. Brovkina, Alexey G. Nikitin
Formato: article
Lenguaje:RU
Publicado: Eco-vector 2021
Materias:
R
Acceso en línea:https://doaj.org/article/f188be48a67348c79d1798ffd8d2b72d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!